Showing 19,821 - 19,840 results of 21,342 for search '(( significantly ((worse decrease) OR (a decrease)) ) OR ( significant decrease decrease ))', query time: 0.47s Refine Results
  1. 19821

    Supplementary Material for: DOT1L regulates cellular senescence during the progression from acute kidney injury to chronic kidney disease via the micro-222-5p/WNT9B signaling pathw... by figshare admin karger (2628495)

    Published 2025
    “…Background: Acute kidney injury (AKI) is a common clinical condition where cellular senescence plays a crucial role in its progression. …”
  2. 19822

    Flexible Microfluidic Devices for Tunable Formation of Double Emulsion by Uditha Roshan (20841937)

    Published 2025
    “…Microfluidic emulsification is a promising method for producing highly monodisperse double-emulsion droplets with a high encapsulation efficiency. …”
  3. 19823

    Flexible Microfluidic Devices for Tunable Formation of Double Emulsion by Uditha Roshan (20841937)

    Published 2025
    “…Microfluidic emulsification is a promising method for producing highly monodisperse double-emulsion droplets with a high encapsulation efficiency. …”
  4. 19824

    Table 1_Oral bacterial community dynamics during induction of gingival inflammation.xlsx by Bart J. F. Keijser (16884185)

    Published 2025
    “…</p>Results<p>The study revealed pronounced microbial changes, particularly in supragingival plaque, where Leptotrichia and Prevotella increased while Streptococcus decreased. Alpha diversity significantly increased in supragingival plaque, tongue, and saliva during gingivitis induction, highlighting shifts in microbial complexity. …”
  5. 19825

    Data Sheet 1_The effect of establishment method and shade zones within solar arrays on pasture production in agrivoltaics production system.docx by Azad Dazaea (22173454)

    Published 2025
    “…Pastures were harvested periodically over two growing seasons from four 1 m-wide zones (A to D) within the alleys between arrays, with shading intensity decreasing from zone A (south side, under the panels) to zone D (north side of the alley). …”
  6. 19826

    Data Sheet 1_Salvia deserti Decne., an endemic and rare subshrub from Arabian desert: antidiabetic and antihyperlipidemic effects of leaf hydroethanolic extracts.doc by Arbi Guetat (3068151)

    Published 2025
    “…</p>Results<p>Oral administration of hydroethanolic extract of S. deserti at 200 and 400 mg/kg for 14 days significantly decreased blood glucose and restored the hepatic and renal function by reducing the levels of ALT, AST, ALP, GGT, LDH, urea and creatinine. …”
  7. 19827

    Flexible Microfluidic Devices for Tunable Formation of Double Emulsion by Uditha Roshan (20841937)

    Published 2025
    “…Microfluidic emulsification is a promising method for producing highly monodisperse double-emulsion droplets with a high encapsulation efficiency. …”
  8. 19828

    Flexible Microfluidic Devices for Tunable Formation of Double Emulsion by Uditha Roshan (20841937)

    Published 2025
    “…Microfluidic emulsification is a promising method for producing highly monodisperse double-emulsion droplets with a high encapsulation efficiency. …”
  9. 19829

    Flexible Microfluidic Devices for Tunable Formation of Double Emulsion by Uditha Roshan (20841937)

    Published 2025
    “…Microfluidic emulsification is a promising method for producing highly monodisperse double-emulsion droplets with a high encapsulation efficiency. …”
  10. 19830

    Figure 6 from Distant Metastases of Breast Cancer Resemble Primary Tumors in Cancer Cell Composition but Differ in Immune Cell Phenotypes by Laura Kuett (20493991)

    Published 2025
    “…<b>F</b> and <b>G,</b> Immune cell phenotypic cluster enrichment in each clinical breast cancer subtype (<b>F</b>) or metastasis-defined patient group (<b>G</b>) at metastatic sites compared with average metastasis composition by differential abundance testing. Circles display significantly enriched (red) or decreased (blue; FDR < 0.05; multiple testing correction with the Benjamin–Hochberg method) results, with size indicating the log-transformed fold change.  …”
  11. 19831

    Supplementary file 1_Oral bacterial community dynamics during induction of gingival inflammation.docx by Bart J. F. Keijser (16884185)

    Published 2025
    “…</p>Results<p>The study revealed pronounced microbial changes, particularly in supragingival plaque, where Leptotrichia and Prevotella increased while Streptococcus decreased. Alpha diversity significantly increased in supragingival plaque, tongue, and saliva during gingivitis induction, highlighting shifts in microbial complexity. …”
  12. 19832

    Flexible Microfluidic Devices for Tunable Formation of Double Emulsion by Uditha Roshan (20841937)

    Published 2025
    “…Microfluidic emulsification is a promising method for producing highly monodisperse double-emulsion droplets with a high encapsulation efficiency. …”
  13. 19833

    Data Sheet 3_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  14. 19834

    Data Sheet 1_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  15. 19835

    Data Sheet 8_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  16. 19836

    Data Sheet 9_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  17. 19837

    Data Sheet 4_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  18. 19838

    Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  19. 19839

    Data Sheet 11_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  20. 19840

    Data Sheet 5_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”